Ascidian Therapeutics

Boston, United States

Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.

$40.0M raised

Nov 2023

Series A

Biotechnology Genetics Medical Therapeutics

Top Investors

Apple Tree Partners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ascidian Therapeutics

How much funding has Ascidian Therapeutics raised?

Ascidian Therapeutics has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in November 2023.

Who are Ascidian Therapeutics's investors?

Ascidian Therapeutics's investors include Apple Tree Partners.

Where is Ascidian Therapeutics headquartered?

Ascidian Therapeutics is headquartered in Boston, United States.

What does Ascidian Therapeutics do?

Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.

What stage is Ascidian Therapeutics at?

Ascidian Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 8, 2023.

MLA

"Ascidian Therapeutics — Funding & Investors." VCBacked, November 8, 2023, https://www.vcbacked.co/company/ascidian-therapeutics. Accessed June 9, 2026.

APA

VCBacked. (2023). Ascidian Therapeutics — Funding & Investors. Retrieved June 9, 2026, from https://www.vcbacked.co/company/ascidian-therapeutics

Wikipedia (cite web)

{{cite web |title=Ascidian Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ascidian-therapeutics |website=VCBacked |access-date=June 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 8, 2023.